<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Akinci G</submitter><funding>NIDDK NIH HHS</funding><funding>National Institutes of Health</funding><funding>Southwestern Medical Foundation</funding><funding>NIH HHS</funding><pagination>e63533</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11060913</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>194(6)</volume><pubmed_abstract>Morbidity and mortality rates in patients with autosomal recessive, congenital generalized lipodystrophy type 4 (CGL4), an ultra-rare disorder, remain unclear. We report on 30 females and 16 males from 10 countries with biallelic null variants in CAVIN1 gene (mean age, 12 years; range, 2 months to 41 years). Hypertriglyceridemia was seen in 79% (34/43), hepatic steatosis in 82% (27/33) but diabetes mellitus in only 21% (8/44). Myopathy with elevated serum creatine kinase levels (346-3325 IU/L) affected all of them (38/38). 39% had scoliosis (10/26) and 57% had atlantoaxial instability (8/14). Cardiac arrhythmias were detected in 57% (20/35) and 46% had ventricular tachycardia (16/35). Congenital pyloric stenosis was diagnosed in 39% (18/46), 9 had esophageal dysmotility and 19 had intestin</pubmed_abstract><journal>American journal of medical genetics. Part A</journal><pubmed_title>Metabolic and other morbid complications in congenital generalized lipodystrophy type 4.</pubmed_title><pmcid>PMC11060913</pmcid><funding_grant_id>R01 DK105448</funding_grant_id><funding_grant_id>R01‐DK105448</funding_grant_id><funding_grant_id>R01-DK105448</funding_grant_id><pubmed_authors>Hamed A</pubmed_authors><pubmed_authors>Alhashmi N</pubmed_authors><pubmed_authors>Sorkina E</pubmed_authors><pubmed_authors>Kamrath C</pubmed_authors><pubmed_authors>Al Senani A</pubmed_authors><pubmed_authors>Al Hosin A</pubmed_authors><pubmed_authors>Can E</pubmed_authors><pubmed_authors>Chakraborty PP</pubmed_authors><pubmed_authors>Oral EA</pubmed_authors><pubmed_authors>Babalola F</pubmed_authors><pubmed_authors>Beghini M</pubmed_authors><pubmed_authors>Scherer T</pubmed_authors><pubmed_authors>Simsir IY</pubmed_authors><pubmed_authors>Patni N</pubmed_authors><pubmed_authors>Tuysuz B</pubmed_authors><pubmed_authors>Cavdar U</pubmed_authors><pubmed_authors>Simha V</pubmed_authors><pubmed_authors>Garg A</pubmed_authors><pubmed_authors>Topaloglu H</pubmed_authors><pubmed_authors>Akinci B</pubmed_authors><pubmed_authors>Saydam BO</pubmed_authors><pubmed_authors>Akinci G</pubmed_authors><pubmed_authors>Curtis J</pubmed_authors><pubmed_authors>Gagne N</pubmed_authors><pubmed_authors>Dursun F</pubmed_authors><pubmed_authors>Muniraj K</pubmed_authors><pubmed_authors>Alyaarubi S</pubmed_authors><pubmed_authors>Allawati M</pubmed_authors><pubmed_authors>Elsayed SM</pubmed_authors><pubmed_authors>Huseinbegovic T</pubmed_authors><pubmed_authors>Al-Shidhani A</pubmed_authors><pubmed_authors>Prodam F</pubmed_authors><pubmed_authors>Al Maimani A</pubmed_authors><pubmed_authors>Wabitsch M</pubmed_authors><pubmed_authors>Dogan OA</pubmed_authors><pubmed_authors>Vaishnav MS</pubmed_authors><pubmed_authors>Comunoglu N</pubmed_authors><pubmed_authors>Brown RJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metabolic and other morbid complications in congenital generalized lipodystrophy type 4.</name><description>Morbidity and mortality rates in patients with autosomal recessive, congenital generalized lipodystrophy type 4 (CGL4), an ultra-rare disorder, remain unclear. We report on 30 females and 16 males from 10 countries with biallelic null variants in CAVIN1 gene (mean age, 12 years; range, 2 months to 41 years). Hypertriglyceridemia was seen in 79% (34/43), hepatic steatosis in 82% (27/33) but diabetes mellitus in only 21% (8/44). Myopathy with elevated serum creatine kinase levels (346-3325 IU/L) affected all of them (38/38). 39% had scoliosis (10/26) and 57% had atlantoaxial instability (8/14). Cardiac arrhythmias were detected in 57% (20/35) and 46% had ventricular tachycardia (16/35). Congenital pyloric stenosis was diagnosed in 39% (18/46), 9 had esophageal dysmotility and 19 had intestin</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-06-03T06:35:44.782Z</modification><creation>2026-04-25T03:20:43.138Z</creation></dates><accession>S-EPMC11060913</accession><cross_references><pubmed>38234231</pubmed><doi>10.1002/ajmg.a.63533</doi></cross_references></HashMap>